SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-03-001690
Filing Date
2003-12-23
Accepted
2003-12-22 20:16:56
Documents
9
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a95295e10vk.htm 10-K 879508
3 EXHIBIT 4.2 a95295exv4w2.txt EX-4.2 35661
4 EXHIBIT 10.4 a95295exv10w4.txt EX-10.4 26157
5 EXHIBIT 21.1 a95295exv21w1.txt EX-21.1 583
6 EXHIBIT 23.1 a95295exv23w1.txt EX-23.1 671
7 EXHIBIT 31.1 a95295exv31w1.txt EX-31.1 2799
8 EXHIBIT 31.2 a95295exv31w2.txt EX-31.2 2803
9 EXHIBIT 32.1 a95295exv32w1.txt EX-32.1 1309
10 EXHIBIT 32.2 a95295exv32w2.txt EX-32.2 1305
  Complete submission text file 0000936392-03-001690.txt   953359
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 031069185
SIC: 2834 Pharmaceutical Preparations